These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26103616)

  • 1. Supporting malaria elimination with 21st century antimalarial agent drug discovery.
    Diagana TT
    Drug Discov Today; 2015 Oct; 20(10):1265-70. PubMed ID: 26103616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The  early  preclinical and clinical development of ganaplacide (KAF156), a novel antimalarial compound.
    Koller R; Mombo-Ngoma G; Grobusch MP
    Expert Opin Investig Drugs; 2018 Oct; 27(10):803-810. PubMed ID: 30223692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current therapies and future possibilities for drug development against liver-stage malaria.
    Raphemot R; Posfai D; Derbyshire ER
    J Clin Invest; 2016 Jun; 126(6):2013-20. PubMed ID: 27249674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressing the global antimalarial portfolio: finding drugs which target multiple Plasmodium life stages.
    Smith PW; Diagana TT; Yeung BK
    Parasitology; 2014 Jan; 141(1):66-76. PubMed ID: 23746048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spiroindolone NITD609 is a novel antimalarial drug that targets the P-type ATPase PfATP4.
    Turner H
    Future Med Chem; 2016; 8(2):227-38. PubMed ID: 26824174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trial watch: Next-generation antimalarial from phenotypic screen shows clinical promise.
    Cully M
    Nat Rev Drug Discov; 2014 Oct; 13(10):717. PubMed ID: 25270950
    [No Abstract]   [Full Text] [Related]  

  • 7. Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development.
    Na-Bangchang K; Karbwang J
    Fundam Clin Pharmacol; 2009 Aug; 23(4):387-409. PubMed ID: 19709319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host-based Prophylaxis Successfully Targets Liver Stage Malaria Parasites.
    Douglass AN; Kain HS; Abdullahi M; Arang N; Austin LS; Mikolajczak SA; Billman ZP; Hume JCC; Murphy SC; Kappe SHI; Kaushansky A
    Mol Ther; 2015 May; 23(5):857-865. PubMed ID: 25648263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Development Process for Discovery and Clinical Advancement of Modern Antimalarials.
    Ashton TD; Devine SM; Möhrle JJ; Laleu B; Burrows JN; Charman SA; Creek DJ; Sleebs BE
    J Med Chem; 2019 Dec; 62(23):10526-10562. PubMed ID: 31385706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resisting resistance: is there a solution for malaria?
    Verlinden BK; Louw A; Birkholtz LM
    Expert Opin Drug Discov; 2016; 11(4):395-406. PubMed ID: 26926843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission.
    Kuhen KL; Chatterjee AK; Rottmann M; Gagaring K; Borboa R; Buenviaje J; Chen Z; Francek C; Wu T; Nagle A; Barnes SW; Plouffe D; Lee MC; Fidock DA; Graumans W; van de Vegte-Bolmer M; van Gemert GJ; Wirjanata G; Sebayang B; Marfurt J; Russell B; Suwanarusk R; Price RN; Nosten F; Tungtaeng A; Gettayacamin M; Sattabongkot J; Taylor J; Walker JR; Tully D; Patra KP; Flannery EL; Vinetz JM; Renia L; Sauerwein RW; Winzeler EA; Glynne RJ; Diagana TT
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5060-7. PubMed ID: 24913172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiology. Is the tide turning for new malaria medicines?
    Wells TN
    Science; 2010 Sep; 329(5996):1153-4. PubMed ID: 20813940
    [No Abstract]   [Full Text] [Related]  

  • 13. An Update on Development of Small-Molecule Plasmodial Kinase Inhibitors.
    Moolman C; Sluis RV; Beteck RM; Legoabe LJ
    Molecules; 2020 Nov; 25(21):. PubMed ID: 33171706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimalarial compounds in Phase II clinical development.
    Held J; Jeyaraj S; Kreidenweiss A
    Expert Opin Investig Drugs; 2015 Mar; 24(3):363-82. PubMed ID: 25563531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovering New Transmission-Blocking Antimalarial Compounds: Challenges and Opportunities.
    Birkholtz LM; Coetzer TL; Mancama D; Leroy D; Alano P
    Trends Parasitol; 2016 Sep; 32(9):669-681. PubMed ID: 27209388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmodium cell biology should inform strategies used in the development of antimalarial transmission-blocking drugs.
    Delves MJ
    Future Med Chem; 2012 Dec; 4(18):2251-63. PubMed ID: 23234549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Basis for Rapid Clearance of Circulating Ring-Stage Malaria Parasites by the Spiroindolone KAE609.
    Zhang R; Suwanarusk R; Malleret B; Cooke BM; Nosten F; Lau YL; Dao M; Lim CT; Renia L; Tan KS; Russell B
    J Infect Dis; 2016 Jan; 213(1):100-4. PubMed ID: 26136472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimalarial drug discovery - the path towards eradication.
    Burrows JN; Burlot E; Campo B; Cherbuin S; Jeanneret S; Leroy D; Spangenberg T; Waterson D; Wells TN; Willis P
    Parasitology; 2014 Jan; 141(1):128-39. PubMed ID: 23863111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single dose treatment of malaria - current status and perspectives.
    Mischlinger J; Agnandji ST; Ramharter M
    Expert Rev Anti Infect Ther; 2016 Jul; 14(7):669-78. PubMed ID: 27254098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in malaria drug discovery.
    Biamonte MA; Wanner J; Le Roch KG
    Bioorg Med Chem Lett; 2013 May; 23(10):2829-43. PubMed ID: 23587422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.